Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.2.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.48NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.60NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CJ.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HZ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.69NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.98NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.71NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HT.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.90NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.18.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.26.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used